Research ArticleMusculoskeletal
18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
Journal of Nuclear Medicine May 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667
Seock-Jin Chung
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
2Tumor Biology Program, Seoul National University College of Medicine, Seoul, Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Hai-Jeon Yoon
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
4Department of Nuclear Medicine, College of Medicine, Ewha Womans University, Seoul, Korea
Hyewon Youn
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
5Tumor Microenvironment Global Core Research Center, Seoul National University College of Medicine, Seoul, Korea
6Cancer Imaging Center, Seoul National University Hospital, Seoul, Korea
Mi Jeong Kim
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Yun-Sang Lee
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
7Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
Jae Min Jeong
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
7Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
8Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; and
June-Key Chung
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
2Tumor Biology Program, Seoul National University College of Medicine, Seoul, Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
5Tumor Microenvironment Global Core Research Center, Seoul National University College of Medicine, Seoul, Korea
7Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
8Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; and
Keon Wook Kang
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
2Tumor Biology Program, Seoul National University College of Medicine, Seoul, Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
6Cancer Imaging Center, Seoul National University Hospital, Seoul, Korea
7Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
8Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; and
Lin Xie
9Department of Radiopharmaceutical Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan
Ming-Rong Zhang
9Department of Radiopharmaceutical Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan
Gi Jeong Cheon
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
2Tumor Biology Program, Seoul National University College of Medicine, Seoul, Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
7Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 5
May 1, 2018
18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang, Gi Jeong Cheon
Journal of Nuclear Medicine May 2018, 59 (5) 839-845; DOI: 10.2967/jnumed.117.200667
18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang, Gi Jeong Cheon
Journal of Nuclear Medicine May 2018, 59 (5) 839-845; DOI: 10.2967/jnumed.117.200667
Jump to section
Related Articles
Cited By...
- No citing articles found.